Stay updated on Pembrolizumab in HCC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in HCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in HCC Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    A sitewide NIH notice announces a transition-related update to terminology, including the use of “Super Intelligence” in place of “Artificial Intelligence.”
    Difference
    1%
    Check dated 2026-10-25T15:55:44.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.1 to v3.7.2 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-18T20:47:52.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.0 to v3.7.1 while the page continued to show a 403 error.
    Difference
    0.2%
    Check dated 2026-10-11T20:48:51.000Z thumbnail image
  4. Check
    37 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error screen with minimal navigation, replacing the previous study details for the NCT03163992 trial; the content sections and links related to the trial have been removed or hidden.
    Difference
    17%
    Check dated 2026-09-20T20:14:51.000Z thumbnail image
  5. Check
    58 days ago
    Change Detected
    Summary
    The page shows Revision: v3.6.6, replacing the previous revision tag, indicating a minor maintenance update. It does not change study details or how users interact with the page.
    Difference
    0.1%
    Check dated 2026-08-30T21:50:44.000Z thumbnail image
  6. Check
    79 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.5, replacing the previous v3.6.4. This indicates a minor update to the page version.
    Difference
    0.1%
    Check dated 2026-08-09T10:56:08.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in HCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in HCC Clinical Trial page.